Patent · US Expired

Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease

US7597894B2 · kind B2 · utility

8Cited by
3References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 5, 2004
Grant dateOct 6, 2009
Priority date
Expiry dateOct 1, 2025

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/828
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are alternative reading frame (ARF) polypeptides as well as antigen presenting cell (APC) and dendritic cell (DC) based compositions and methods that employ alternative reading frame polypeptides. ARF polypeptides and ARF polypeptide-based compositions and methods are useful in the treatment of cancer and infectious disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.